Assessment of ADC Values and Radiomics Characteristics With a MRI of the Prostate to Identify Tumor Lesions

Recruiting now

Conditions studied: Prostate Cancer (Adenocarcinoma)

In brief

The goal of this observational study is to assess the chance to predict prostate cancer with the analysis of specific values found in images obtained from RMmp (multiparametric magnetic resonance imaging) of patients who went through the procedure at IRCCS Azienda Ospedaliero-Universitaria hospital in the city of Bologna from September 2015 to March 2021. The main question it aims to answer is: \- does the analysis of ADC values and radiomics values found in the RMmp images help with the detection of prostate cancer?

Key facts

Study ID

NCT06774781

Run by

IRCCS Azienda Ospedaliero-Universitaria di Bologna

People needed

120

Starts

2021-10-23

Expected to finish

2025-01-31

Last updated by the study team

2025-01-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Presence of one or more lesions classified as PI-RADSv2.1 ≥ 3 at a prostate RMmp at the IRCCS Azienda Ospedaliero-Universitaria in Bologna
• Indication for eco-guided targeted biopsy by fusion technique integrated with systematic biopsy
• Indication for radical prostatectomy
• Participants aged 18 at the time of examination
• Obtaining informed consent.

You may not qualify if…

• Impossibility of performing MRI (claustrophobic or obese participants etc.) or contraindications to the execution of MRI
• Technically sub-optimal investigations for the presence of artifacts (hip prosthesis, movement of the endorectal probe, etc.)

Where it is running

• IRCCS Azienda Ospedaliero-Universitaria di Bologna — Bologna, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.